palifermin
Showing 1 - 25 of 39
Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)
Active, not recruiting
- Leukemia
- +3 more
- Palifermin
- +6 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 23, 2023
Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,
Recruiting
- Myelodysplastic Syndrome
- +4 more
- Rituximab
- +6 more
-
Bethesda, Maryland
- +1 more
Aug 20, 2022
T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)
Terminated
- T-cell Non-Hodgkin Lymphoma
- Cyclophosphamide
- +12 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2023
X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Suspended
- X-linked Severe Combined Immunodeficiency (XSCID)
- Palifermin
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Epidermolysis Bullosa Trial in Aurora, Chicago, New York (Palifermin, Fludarabine, Busulfan)
Terminated
- Epidermolysis Bullosa
- Palifermin
- +5 more
-
Aurora, Colorado
- +2 more
Aug 13, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 12, 2023
Myeloma Trial in Houston (Palifermin, Dexamethasone, Gemcitabine)
Completed
- Myeloma
- Palifermin
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 23, 2020
Lymphoma Trial in Houston (Gemcitabine, Busulfan, Melphalan)
Completed
- Lymphoma
- Gemcitabine
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 13, 2019
X-Linked Combined Immunodeficiency Diseases Trial run by the NIAID (CD34+ HSCs transduced with the lentivirus vector, VSV-G
Unknown status
- X-Linked Combined Immunodeficiency Diseases
- CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1α-hγc-OPT
- +2 more
-
Bethesda, MarylandLaboratory of Host Defenses (LHD), National Institute of Allergy
Dec 3, 2019
Lymphoma Trial in Houston (Lenalidomide, Vorinostat, Gemcitabine)
Terminated
- Lymphoma
- Lenalidomide
- +12 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 26, 2019
Multiple Sclerosis Trial in Cambridge (Palifermin, Alemtuzumab)
Terminated
- Multiple Sclerosis
- Palifermin
- Alemtuzumab
-
Cambridge, Cambridgeshire, United KingdomAddenbrooke's Hospital
Apr 26, 2019
Gastrointestinal Mucositis, Malignant Tumor Trial (Palifermin, Placebo)
Withdrawn
- Gastrointestinal Mucositis
- Malignant Neoplasm
- Palifermin
- Placebo
- (no location specified)
Aug 3, 2018
Hematopoietic and Lymphoid Cell Tumor, Hematopoietic Cell Transplantation Recipient Trial in Duarte (procedure, drug, other,
Withdrawn
- Hematopoietic and Lymphoid Cell Neoplasm
- Hematopoietic Cell Transplantation Recipient
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 5, 2018
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplasia Trial in Indianapolis (radiation, drug, biological)
Terminated
- Acute Myeloid Leukemia
- +3 more
- Total Body Irradiation
- +4 more
-
Indianapolis, IndianaIndiana University Cancer Center
Mar 12, 2018
Mucositis, Head Neck Cancer Trial (Placebo, palifermin, Radiotherapy)
Completed
- Mucositis
- Head and Neck Cancer
- Placebo
- +3 more
- (no location specified)
May 29, 2017
Head Neck Cancer, Mucositis, Pain Trial in Canada, United States (biological, drug, other, procedure, radiation)
Terminated
- Head and Neck Cancer
- +3 more
- palifermin
- +4 more
-
Scottsdale, Arizona
- +47 more
Nov 28, 2017
Plasma Cell Leukemia in Remission, Plasma Cell Myeloma Trial in Duarte (procedure, drug, biological, other, radiation)
Withdrawn
- Plasma Cell Leukemia in Remission
- Plasma Cell Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 11, 2017
Head Neck Cancer Trial (Placebo, Palifermin)
Completed
- Head and Neck Cancer
- Placebo
- Palifermin
- (no location specified)
Dec 14, 2016
Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome Trial in Bridgeport, New Haven (Palifermin)
Terminated
- Toxic Epidermal Necrolysis
- Stevens-Johnson Syndrome
- Palifermin
-
Bridgeport, Connecticut
- +1 more
Oct 6, 2016
Lymphoma Trial (drug, other, biological)
Withdrawn
- Lymphoma
- Palifermin
- +12 more
- (no location specified)
Apr 20, 2017
Lymphoma Trial in Houston (Vorinostat, Gemcitabine, Busulfan)
Completed
- Lymphoma
- Vorinostat
- +8 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 17, 2015
Mucositis Trial (Palifermin)
Unknown status
- Mucositis
- Palifermin
- (no location specified)
Dec 8, 2014